Literature DB >> 28967879

MicroRNA 31 inhibits CD8+ T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection.

Mingming Jia1,2, Yiming Shao1, Kunxue Hong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28967879      PMCID： PMC6068143          DOI： 10.1038/cmi.2017.99

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  9 in total

Review 1.  Immuno-miRs: critical regulators of T-cell development, function and ageing.

Authors:  Bart-Jan Kroesen; Nato Teteloshvili; Katarzyna Smigielska-Czepiel; Elisabeth Brouwer; Anne Mieke H Boots; Anke van den Berg; Joost Kluiver
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

2.  The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection.

Authors:  Howell F Moffett; Adam N R Cartwright; Hye-Jung Kim; Jernej Godec; Jason Pyrdol; Tarmo Äijö; Gustavo J Martinez; Anjana Rao; Jun Lu; Todd R Golub; Harvey Cantor; Arlene H Sharpe; Carl D Novina; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2017-05-22       Impact factor: 25.606

Review 3.  Type I Interferon in Chronic Virus Infection and Cancer.

Authors:  Laura M Snell; Tracy L McGaha; David G Brooks
Journal:  Trends Immunol       Date:  2017-05-31       Impact factor: 16.687

4.  Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.

Authors:  Redouane Rouas; Hussein Fayyad-Kazan; Nabil El Zein; Philippe Lewalle; Françoise Rothé; Alexandru Simion; Haidar Akl; Mohamad Mourtada; Mohamad El Rifai; Arsène Burny; Pedro Romero; Philippe Martiat; Bassam Badran
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

5.  MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Authors:  Jan C Dudda; Bruno Salaun; Yun Ji; Douglas C Palmer; Gwennaelle C Monnot; Estelle Merck; Caroline Boudousquie; Daniel T Utzschneider; Thelma M Escobar; Rachel Perret; Stefan A Muljo; Michael Hebeisen; Nathalie Rufer; Dietmar Zehn; Alena Donda; Nicholas P Restifo; Werner Held; Luca Gattinoni; Pedro Romero
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

6.  miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation.

Authors:  F Xue; H Li; J Zhang; J Lu; Y Xia; Q Xia
Journal:  Genes Immun       Date:  2013-01-10       Impact factor: 2.676

7.  The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.

Authors:  Khalda Sayed Amr; Faten S Bayoumi; Fatema T Elgengehy; Sanaa O Abdallah; Hanan H Ahmed; Eman Eissa
Journal:  Rheumatol Int       Date:  2016-08-10       Impact factor: 2.631

8.  The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.

Authors:  Donald T Gracias; Erietta Stelekati; Jennifer L Hope; Alina C Boesteanu; Travis A Doering; Jillian Norton; Yvonne M Mueller; Joseph A Fraietta; E John Wherry; Martin Turner; Peter D Katsikis
Journal:  Nat Immunol       Date:  2013-04-21       Impact factor: 25.606

Review 9.  MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response.

Authors:  Samuel C Forster; Michelle D Tate; Paul J Hertzog
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.